drugset / Trial / NCT00004046

Chemotherapy in Treating Women With Metastatic Breast Cancer

NCT00004046

Phase 2 Completed Daiichi Sankyo
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating women who have metastatic breast cancer that has not responded to previous therapy.

Timeline

Start
1999-06
Primary completion
2002-04
Completion
2002-04

Drugs

EvaluationDrugModalityDoseRoute
Subject exatecan Small molecule Intravenous

Indications